Stay updated on Sabatolimab & Magrolimab Treatment in AML Clinical Trial
Sign up to get notified when there's something new on the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page.

Latest updates to the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added to the history, and the funding-status notice along with Revision: v3.4.1 were removed.SummaryDifference0.9%

- Check21 days agoChange DetectedA site-wide government funding notice has been added to the top of the page, and the revision history now shows a new Revision: v3.4.1 replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check28 days agoChange DetectedThe new version adds a 'Show glossary' option and color-coded change indicators (green for additions, red for deletions) with notes like 'Data that is changed in the study record is color coded' and 'Revision: v3.4.0'. Older entries such as 'No FEAR Act data' and 'Revision: v3.3.4' were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check42 days agoChange DetectedThe history shows a new revision (v3.3.4) added and v3.3.3 removed from the study's record history; these are minor metadata updates to the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA new Revision: v3.3.3 entry was added to the history, and the HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check85 days agoChange DetectedRecord History shows a new revision entry: v3.3.2, replacing the previous v3.3.1. This is a minor metadata update to the page history.SummaryDifference0.1%

Stay in the know with updates to Sabatolimab & Magrolimab Treatment in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page.